Kerala Ayurveda share price
You have to be logged in to add this to Watchlist.- ₹324.75(-0.92%)April 22, 2025 15:29:30 PM IST
- NSE
- BSE
- Vol : 2.48K (NSE + BSE)Last 20 day avg : 9.54 K
Kerala Ayurveda is trading -0.92% lower at Rs 324.75 as compared to its last closing price. Kerala Ayurveda has been trading in the price range of 329.80 & 322.00. Kerala Ayurveda has given -25.63% in this year & -3.56% in the last 5 days. Kerala Ayurveda has TTM P/E ratio 439.94 as compared to the sector P/E of 28.79.The company posted a net profit of -2.89 Crores in its last quarter.Listed peers of Kerala Ayurveda include Gpt Healthcare (0.18%), Forbes And Company (3.06%), Kerala Ayurveda (-0.92%).The Mutual Fund holding in Kerala Ayurveda was at 0.02% in 31 Mar 2025. The MF holding has decreased from the last quarter. The FII holding in Kerala Ayurveda was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Apr 22, 2025, 07:13 PM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/B12.26The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values327.19Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.36Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry2.10The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is not profitable
The company's revenue grew in December quarter by 18.28% from Rs 31.13 crore to Rs 26.32 crore, year-on-year- The company has increased its December quarter loss by 188.67% from Rs 1.00 crore to Rs 2.89 crore, year-on-year
- The debt to equity of the company is higher than the industry median
- Earnings are insufficient to cover the interest expenses on outstanding debt
- R1
- 383.40
- R2
- 415.60
- R3
- 447.30
- S1
- 319.50
- S2
- 287.80
- S3
- 255.60
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Gpt Healthcare | Moderately Bullish | 167.30 | 0.18 | 1,366.13 | 27.67 | 6.18 | 1.22 | 8.68 |
| Forbes And Company | Neutral | 369.90 | 3.06 | 477.73 | 79.22 | 3.2 | - | 3.57 |
| Kerala Ayurveda | Bearish | 324.75 | -0.92 | 399.12 | - | 12.32 | - | 184.73 |
| Aashka Hospitals | Bearish | 103.95 | -1.84 | 243.25 | 104.96 | 2.57 | - | 8.59 |
| Fortis Malar Hospitals | Bullish | 84.96 | -1.03 | 158.84 | 20.88 | 1.46 | 49.72 | - |
- Pledged found - Promoter(s) have pledged 13.36% of shares.
- Pledging Flat - Promoter(s) pledging has not increased in last quarter.
- Promoter(s) holds a high stake in the company at 58.58%
- FIIs are not invested in this company
- Mutual Funds holding is constant over the last quarter at 0.02%
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-02-14 | Quarterly Results |
| 2024-12-09 | Preferential issue of shares |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
| 2024-05-29 | Audited Results |
- IndustryHealthcare Facilities
- ISININE817B01025
- BSE Code530163
- NSE Code
Kerala Ayurveda is trading at 324.75 as on Tue Apr 22 2025 09:59:30. This is -0.92% lower as compared to its previous closing price of 327.75.
The market capitalization of Kerala Ayurveda is 399.12 Cr as on Tue Apr 22 2025 09:59:30.
The 52 wk high for Kerala Ayurveda is 486.90 whereas the 52 wk low is 250.00
Kerala Ayurveda can be analyzed on the following key metrics -
- TTM P/E: 439.94
- Sector P/E: 28.79
- Dividend Yield: 0.00%
- D/E ratio: -
Kerala Ayurveda reported a net profit of -1.53 Cr in 2024.
The Mutual Fund Shareholding was 0.02% at the end of 31 Mar 2025.